41 / 1084
MDCT - Restaging after neoadjuvant chemotherapy
•
Predicted T stage correctly in
34 %
(12/35)
•
Overstaged 49 %
(17/35)
•
Understaged 17 %
(6/35)*
Accurate N stage was noted in
69 %
(24/35)
•
•
Assessment of oesophageal tumour response
should focus on
combined morphologic and
metabolic imaging
*Konieczny, A., P. Meyer, et al. (2013). Eur Radiol 23(9): 2492-2502.